FSD Pharma Inc Ordinary Shares - Class B (Sub Voting) HUGE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CAD 0.53
- Day Range
- CAD 0.50–0.56
- 52-Week Range
- CAD 0.50–2.23
- Bid/Ask
- CAD 0.51 / CAD 0.52
- Market Cap
- CAD 20.62 Mil
- Volume/Avg
- 45,206 / 49,808
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 19.37%
Company Profile
FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The Company operates in two segments: Biotechnology and Strategic Investments.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 8
- Website
- https://www.fsdpharma.com
Valuation
|
Metric
|
HUGE
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.44 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
HUGE
Financial Strength
|
Metric
|
HUGE
|
|---|---|
Quick Ratio | 2.39 |
Current Ratio | 2.43 |
Interest Coverage | −63,600.84 |
Quick Ratio
HUGE
Profitability
|
Metric
|
HUGE
|
|---|---|
Return on Assets (Normalized) | −40.00% |
Return on Equity (Normalized) | −61.92% |
Return on Invested Capital (Normalized) | −56.06% |
Return on Assets
HUGE
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Lncjxkwzd | Vts | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Rrcdssyx | Xtdvcf | $69.1 Bil | |
HLN
| Haleon PLC ADR | Yblyhdqb | Yqpd | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vyjlmydh | Hfx | $15.6 Bil | |
VTRS
| Viatris Inc | Whrfchhls | Ddcvs | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zgfbnrd | Bsjb | $12.4 Bil | |
CTLT
| Catalent Inc | Ttjqysnq | Zzclb | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Vwtwpcr | Jqy | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Njpmwvv | Gylh | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vswgdbrr | Glllpd | $3.5 Bil |